The Competition council opened an investigation on medicine market* • Possible abuse of dominant position of Boehringer Ingelheim RCV Gmbh&CO. KG The Competition Council opened an investigation into a possible abuse of a dominant position of Boehringer Ingelheim RCV GmbH & Co. KG. KG, Vienna, on the Romanian market for the sale of direct oral anticoagulant medicines and medicines for the treatment of chronic obstructive pulmonary disease. The competition authority has indications that Boehringer Ingelheim RCV GmbH & Co. has
The Romanian Competition Authority opens an investigation into possible abuse of dominant position and restriction on market entry by a pharmaceutical company in the medicines market (Boehringer Ingelheim)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.